Results 231 to 240 of about 1,410,814 (319)
Clinical Efficacy of Chinese patent medicines combined with standard drug treatment for treatment of lupus nephritis in Adults: A Multiple-Treatment Meta-Analysis [PDF]
Liquan yuan +6 more
openalex +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
PROTAC-PatentDB: A PROTAC Patent Compound Dataset. [PDF]
Cai H, Yao G, Shi Y, Zhang T, Hu Y.
europepmc +1 more source
Problem-Solving Convergence Competency-Based Classes - The Case of the Patents as Class Results [PDF]
Hyun-Ju Kim, Jinyoung Lee
openalex +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Patent foramen ovale (PFO) exacerbates intermittent hypoxia in moderate-to-severe obstructive sleep apnea (OSA) patients [PDF]
Yidi Lv +5 more
openalex +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
The Advanced BioTRIZ Method Based on LTE and MPV. [PDF]
Bai Z, Li L, Hao Y, Zhang X.
europepmc +1 more source
Introduction to A Research Agenda for Patent Law [PDF]
Luke McDonagh, Noam Shemtov
openalex +1 more source

